AstraZeneca
AZN | NYSE
$186.65
+$12.25 (+7.02%)
At close: Oct 30, 2026, 4:00 PM ET
$186.06
-$0.59 (-0.32%)
Pre-market:
Nov 2, 2026, 4:17 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | 13.30 | 14.32 | 17.43 | 32.13 | 724.06 | 20.70 |
PEG Ratio | 0.29 | 0.75 | 0.22 | 0.01 | -7.49 | 0.15 |
PS Ratio | 2.32 | 1.86 | 2.26 | 2.38 | 2.20 | 2.49 |
PB Ratio | 2.79 | 2.47 | 2.65 | 2.85 | 2.09 | 4.24 |
P/FCF Ratio | 15.69 | 13.85 | 15.79 | 14.57 | 21.83 | 30.21 |
P/OCF Ratio | 9.33 | 8.49 | 10.03 | 10.75 | 13.77 | 13.81 |
OCF/S Ratio | 24.81 | 21.94 | 22.58 | 22.11 | 15.94 | 18.03 |
Debt / Equity Ratio | 0.61 | 0.74 | 0.73 | 0.79 | 0.78 | 1.30 |
Quick Ratio | 0.72 | 0.74 | 0.64 | 0.68 | 0.76 | 0.76 |
Current Ratio | 0.94 | 0.93 | 0.82 | 0.86 | 1.16 | 0.96 |
Asset Turnover | 0.51 | 0.52 | 0.45 | 0.46 | 0.36 | 0.40 |
Interest Coverage | 8.11 | 5.95 | 5.16 | 2.82 | 0.83 | 4.06 |
Return on Equity | 21.07% | 17.25% | 15.21% | 8.88% | 0.29% | 20.46% |
Return on Assets | 8.99% | 6.76% | 5.89% | 3.41% | 0.11% | 4.79% |
Return on Invested Capital | 13.03% | 10.30% | 9.32% | 4.97% | -0.54% | 8.49% |
Dividend Yield | 3.65% | 4.59% | 4.32% | 4.14% | 4.69% | 5.39% |
Payout Ratio | 48.47% | 65.80% | 75.25% | 132.73% | 3.44K% | 111.76% |
FCF Payout Ratio | 57.34% | 63.63% | 74.83% | 65.94% | 122.49% | 186.43% |
Gross Profit Margin | 81.90% | 81.12% | 81.95% | 72.06% | 66.76% | 80.09% |
Net Profit Margin | 17.46% | 13.01% | 13% | 7.41% | 0.30% | 12.01% |
Pretax Profit Margin | 21.11% | 16.07% | 15.06% | 5.64% | -0.71% | 14.71% |
Operating Profit Margin | 23.40% | 18.50% | 17.88% | 8.47% | 2.82% | 19.39% |
FCF Margin | 14.76% | 13.45% | 14.34% | 16.32% | 10.06% | 8.24% |
EBITDA Margin | 33.76% | 28.55% | 29.30% | 20.48% | 13.66% | 30.37% |
Add to Watchlist
Select watchlists to add or remove AZN